Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Debt Growth Under PressureDecelerating
Percentile Rank78
3Y CAGR+191.0%
5Y CAGR+47.0%
Year-over-Year Change
Year-over-year debt growth rate
3Y CAGR
+191.0%/yr
Quarterly compound
5Y CAGR
+47.0%/yr
Recent acceleration
Percentile
P78
Within normal range
vs 5Y Ago
6.9x
Strong expansion
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 13.49% |
| Q3 2025 | 13.89% |
| Q2 2025 | 0.11% |
| Q1 2025 | -0.12% |
| Q4 2024 | 0.16% |
| Q3 2024 | 0.22% |
| Q2 2024 | 136.53% |
| Q1 2024 | 1.00% |
| Q4 2023 | 0.29% |
| Q3 2023 | 20.34% |
| Q2 2023 | -0.71% |
| Q1 2023 | 24.80% |
| Q4 2022 | 0.55% |
| Q3 2022 | -0.35% |
| Q2 2022 | -1.21% |
| Q1 2022 | 979.53% |
| Q4 2021 | -18.74% |
| Q3 2021 | 8.84% |
| Q2 2021 | 215.81% |
| Q1 2021 | -18.53% |
| Q4 2020 | 1.96% |
| Q3 2020 | -4.68% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |